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Abstract
Background: About two thirds of patients with cervical cancer in Tanzania present with advanced tumor stage,
leading to significant morbidity and mortality. We designed a study to determine the factors associated with the
late tumour stage at presentation among patients with cervical cancer in Mwanza.
Methods: This cross-sectional study recruited women at Bugando Medical Centre (BMC) with histologically
confirmed cervical cancer from November 2013 to April 2014. Patients were recruited serially until the sample size
was reached.
Results: A total of 202 women with histologically confirmed cervical cancer were recruited. The mean age of the
patients was 50.5 ± 13.3 years. The majority of patients (n = 129, 63.9 %) were diagnosed with late stage disease
(IIB-IVB). Patients also presented with severe anemia (n = 78, 38.6 %), urinary tract infections (n = 74, 36.6 %),
hydronephrosis (n = 43, 21.2 %), elevated serum creatinine levels (n = 33, 16.3 %), vesicovaginal fistula (VVF), (n = 13,
6.4 %), lung metastasis (n = 5, 2.4 %), metastasis to the urinary bladder (n = 4, 1.9 %), rectovaginal fistula (RVF) (n = 3,
1.4 %), liver metastasis (n = 2, 0.9 %) and hydroureter (n = 2, 0.9 %). In multivariate logistic regression, factors
associated with late stage at presentation were attending to alternative health practitioners and lack of personal
initiative to seek care to formal health facilities (OR 2.3; 95 % CI 1.2–4.2, p = 0.011 and OR 2.0; 95 % CI 1.0–3.8,
p = 0.028) respectively.
Conclusion: Communities should be sensitized to women’s empowerment, provide community education on early
symptoms of cervical cancer, and the importance of early hospital attendance.
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Background
Cervical cancer is the fourth common cancer among
women worldwide with nearly 529,000 incident cases
and 275,000 deaths each year [1]. More than 85 % of
these cases occur in developing countries due lack of
implementation campaigns aimed at cancer prevention,
such as screening for early detection and vaccination for
Human Papillomavirus (HPV) infection [1]. The highest
burden of cervical cancer-related deaths occur in
developing countries and it is the leading cause of
gynecological cancer-related deaths among women in
Sub-Saharan Africa, Central America and South-Central
Asia [2]. In Tanzania, approximately 3,000 new cervical
cancer patients are seen at Ocean Road Cancer Institute
per year and 47 % of these patients present with ad-
vanced stage disease [3]. At Bugando Medical Centre
(BMC), 400 patients with cervical cancer are seen per
annum [4].
Patients who present with advanced stage disease are
more likely to develop complications such as anemia,
ureteric obstruction with hydroureter and hydronephrosis,
renal failure and urinary tract infection [5, 6]. Cervical
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cancer may present with abnormal vaginal discharge, con-
tact vaginal bleeding, loin pain, changes in urine output,
hematuria and increased serum creatinine, vesicovaginal
fistula (VVF) and rectovaginal fistula (RVF) [7].
In developing countries, due to poor availability of
health services for early screening and diagnosis, patients
often present with advanced stage disease, which is
associated with a poor prognosis and high mortality rate
[8, 9]. Additionally, cultural, social and demographic fac-
tors may be responsible for patients’ presentation with
late stage disease. A study from New Zealand reported
that socioeconomic status and urban/rural residence had
marginal effects [10]. Across all age groups, women in
London with a lack of awareness and knowledge about
cervical cancer were more likely to present with late
stage disease [11]. In Morocco, an increased risk for a
late stage was observed in women who were unmarried,
lived in a rural area or more than 100 km from a diag-
nostic health center, did not have vaginal bleeding as
their first symptom, were less than 50 years old, and
were illiterate [12]. In a study conducted in Korea, other
factors which contribute to the late diagnosis are inad-
equate knowledge of cervical cancer, lack of screening,
and poor diagnostic procedure and treatment among
health care provider [13].
At Bugando Medical Centre (BMC), in northwestern
Tanzania, a previous study has shown that 47.3 % of pa-
tients with cervical cancer present with advanced-stage
disease [4]. In Muhimbili National Hospital, Tanzania,
more than 90 % of patients admitted were in an
advanced disease (stage IIB-IV) and majority of the
patients (50.6 %) were illiterate [14]. Despite these find-
ings, it is not clear what factors contribute to late pres-
entation of cervical cancer in East Africa. As a result, it
has been difficult to develop targeted interventions to
prevent late tumour stage at presentation. Findings from
this study will provide baseline data to hospital author-
ities and policy makers to design effective and equitable
interventions for prevention of late presentation to the
hospital, which can ultimately minimize morbidity and
mortality from cervical cancer.
Methods
A cross-sectional study was conducted with patients
diagnosed with cervical cancer from November 2013 to
April 2014 at BMC, a referral, consultancy and teaching
hospital for the Catholic University of Health & Allied
Sciences (CUHAS) in Mwanza, Tanzania. The hospital
serves about 13 million people from six regions of the
Lake Zone, which are Kagera, Tabora, Shinyanga, Mara,
Kigoma and Mwanza. The hospital has bed capacity for
approximately 800 patients. It has also a well-equipped
pathology laboratory staffed by two pathologists. About
3–4 women with suspected cancerous lesion of the
cervix are seen weekly at the hospital for investigation
and initial care before radical hysterectomy or radiother-
apy. Approximately 400 cases of confirmed cervical can-
cer are seen yearly (BMC, unpubl).
Women who presented with suspected cervical cancer
to BMC were identified and recruited serially until the
sample size was reached. Written informed consent for
participation in the study was obtained from each partic-
ipants. Suspected cervical cancer patients were those
with contact vaginal bleeding/postmenopausal bleeding,
abnormal vaginal discharge, fecal/urine incontinence
and pelvic/loin pain with or without visible cervical
lesion on speculum examination. The final study popu-
lation included women with histologically confirmed
cervical cancer who were eligible for curative treatment.
Patients were excluded if they were not competent to
consent and did not have next of kin to provide in-
formed consent, did not have confirmed cervical cancer,
or who were treated with palliative intent for their cer-
vical cancer.
Data were collected using pre-tested structured ques-
tionnaires. Information collected included clinical and
pathologic staging, age, occupation, education, parity,
marital status, residence, and results from laboratory
and radiological investigations. The staging of carcinoma
of the cervix was determined through bimanual examin-
ation under anesthesia with the support of chest X- ray
and abdominal pelvic ultrasound. A cervical specimen
from suspected cervical cancer patients was taken and
kept in a 5 ml bottle containing 10 % formalin. The
specimens were sent to the histopathology laboratory
and were examined by a pathologist.
Venopuncture was performed where by a tourniquet
3–4 in. above the collection site was applied; the punc-
ture site was cleaned by making a smooth circular pass
over the site with the 70 % alcohol swab. When the skin
dried a venopuncture was done with 5 cc syringe and
4mls of blood was drawn, 2mls of blood were distributed
into plain and EDTA vacutainers and sent to the BMC
laboratory for HIV serostatus, serum creatinine and
hemoglobin level determination. In our hospital, a pa-
tient with confirmed cervical cancer clinical stage I-IIA
are treated surgically (radical hysterectomy & pelvic
lymphadenectomy) and the specimen is sent to the hist-
ology department for pathologic staging. Patients with
advanced stage in both clinical and pathologic staging
are referred for radiotherapy at Ocean Road Cancer
Institute (ORCI). A mid-stream clean catch urine of
approximately 5mls was sent to BMC laboratory for ana-
lysis of urinary tract infections (UTIs) by microscope.
Data were entered into Microsoft Excel and was
analyzed using STATA® data analysis and statistical soft-
ware package version 13 (StataCorp LP., 2013; College
Station, TX, USA).
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Continuous variables were summarized into means
with standard deviations or medians with inter-quartile
range, as appropriate. Categorical variables were summa-
rized into frequencies and percentages. To determine
factors related with late stage at presentation, univariate
analysis was done followed by multivariate logistic re-
gression. Odds ratios with 95 % confidence intervals
were reported.
Ethical review and approval was obtained from the
Joint Catholic University of Health & Allied sciences and
Bugando Medical Centre’s research and publication
committee. Written informed consent was requested
and obtained from all participants in Swahili language
and confidentiality was assured. Patient refusal to par-
ticipate in this study did not jeopardize the quality of
care that the patients received in the hospital.
Results
A total number of 212 patients with clinical diagnosis of
suspected cervical cancer were attended at BMC during
the study period. Ten patients were excluded from the
study; eight patients had no confirmed cancer and 2 pa-
tients did not consent to participate in the study. There
were 202 patients with histologically confirmed cervical
cancer who were included in the study.
Characteristics of the study population
The mean age at presentation was 50.5 ± 13.3 years
(range: 25–80 years). More than half 115 (56.9 %) of pa-
tients had no formal education. Of the patients with for-
mal education, 39.1 % had primary level, 2.4 % had
secondary level and 3 (1.4 %) had college level. Most of
the patients (79.2 %) were coming from rural area, and
majority 170 (84.1 %) were peasant farmers. The vast
majority of patients (94 %, n = 190) had no medical in-
surance (see Table 1).
More than half of patients (54.4 %, n = 110) were living
with their husband/sexual partners at the time of the
study. Most women (73.6 %, n = 149) delivered more
than five times in their lifetime. Forty-four (21.8 %)
women were infected with HIV, and 106 (52.4 %) were
menopausal (see Table 1).
Clinical presentation and histological types
Contact vaginal bleeding was present in nearly all
patients. Other symptoms included abnormal vaginal
discharge (94 %) and pelvic pain (14.6 %). Squamous
cell carcinoma was the most common tumour histology
(see Table 2).
Prevalence of late stage cervical cancer among
participants
Among 202 patients confirmed with cervical cancer,
73 (36.1 %) were found in an early tumour stage. The
prevalence of late stage cervical cancer was 63.9 %
(see Table 2).
The pattern of complications among women with
cervical cancer
Forty three patients (21.2 %) had hydronephrosis; of
these, unilateral hydronephrosis was seen in 65.1 % and
bilateral hydronephrosis in 34.9 % of the patients. Serum
creatinine was elevated in 16.3 % of the patients. VVF
Table 1 Characteristics of the study population
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was seen in 6.4 % of the patients, hydroureter
(0.9 %) and liver metastasis (0.9 %). Other complica-
tions seen were severe anemia (38.6 %) and UTIs
(36.6 %) (see Table 3).
Factors associated with late stage at presentation to the
hospital
Univariate logistic regression was conducted to identify
factors associated with a late tumour stage. Lack of
formal education, lack of health insurance, attending to
an alternative health practitioner, and lack of personal
initiative to attend formal health care facility, and three
or more pre-referral visits were statistically significant
(p <0.05) (Table 4).
In multivariate logistic regression; only attending to
traditional health practitioners and lack of personal
initiative to attend health care facility were associated
with a late tumour stage at presentation (OR = 2.3 [95 %
CI 1.2–4.2], p = 0.011) and OR = 2.0 [95 % CI 1.0–3.8],
p = 0.028) respectively.
Discussion
Despite efforts to curb the morbidity and mortality attrib-
uted to cervical cancer; deaths and complications are the
most burdensome in developing countries, including
Tanzania. The prevalence of late tumour stage at presenta-
tion to the hospital in our study was 63.9 % which is lower
than those seen in studies from Zaria Northern Nigeria
(98 %), Muhimbili National hospital Tanzania (90 %),
Nepal (80.9 %) and India (80 %) [8, 14–16], but higher
than reported in a Morocco study (54.5 %) [12]. The
higher prevalence found in Nigeria, Muhimbili National
Hospital, Nepal, and India could be because their study
sites are located within oncology centers where patients
are referred for radio-chemotherapy; there might be a
delay in referrals causing patients to arrive to these centers
in advanced stage. The difference can also be explained by
geographical variations and socioeconomic status, which
hinder the accessibility to health care facilities and poor
health seeking behaviors, when compared to our study
population. The Morocco study likely reported lower rates
because of differences in classification of advance tumor
stage; their study classified advanced tumour stage as stage
III-IVB, whereas this study categorized advanced tumour
stage as IIB –IVB.
Anemia and hydronephrosis were the most common
complications seen in this study. These findings were
similar to studies done in Uganda and Minnesota [6, 17].
In this study; 65.1 % of the sample had unilateral hydrone-
phrosis, and elevated serum creatinine was found in
16.3 % of all patients. These findings are similar to a study
done in Sub-Saharan Africa where most of their patients
56 % had unilateral hydronephrosis and 15.1 % of patients
had elevated serum creatinine [18]. Our study found that
elevated serum creatinine (16.3 %) was less than what was
previously reported in Uganda (71.4 %) [6]. The low oc-
currence of elevated serum creatinine in our study is due
to the inclusion of all patients with cervical cancer while
for a study in Uganda only patients with hydronephrosis
were included.
In this study VVF was found in 6.4 % of all patients with
cervical cancer which was similar to studies done in
Minnesota (7 %) and Uganda (7.4 %) respectively [6, 17].
Table 2 Clinical presentation and histological types
Patient characteristics N (%)
Clinical presentation
Abnormal Vaginal discharge 190 (94.1)
Contact vaginal bleeding 201 (99.5)










Early stages 73 (36.1)
Late stages 129 (63.9)
Histopathology results
Squamous cell carcinoma 190 (94.1)
Adenocarcinoma 9 (4.4)
Clear cell carcinoma 3 (1.4)





Lung Metastasis 5 (2.4)
Liver Metastasis 2 (0.9)









Serum creatinine >139 mmol/l 33 (16.3)
Urinary tract infections 74 (36.6 )
Hemoglobin <7 g/dl 78 (38.6)
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Attending to alternative health care practitioners and
lack of personal initiative for early attendance to health
care facility were the main factors associated with late
tumour stage at presentation. These findings were
similar to a study done in Uganda [19]. In our study age
and lack of health insurance were not related with a late
stage at presentation, contrary findings from Florida and
Sudan [20, 21]. The difference could be attributed by
Table 4 Logistic regression model for factors associated with late stage at presentation
Variables Late stage Univariate Multivariate
Yes No OR [95 % CI] p-value OR [95 % CI] p-value
n (%) n (%)
Age in years
<40 29 (64.4) 16 (35.6) 1 1
40–59 55 (54.5) 46 (45.5) 0.7 [0.3–1.4] 0.261 0.5 [0.3–1.2] 0.107
≥60 45 (80.4) 11 (19.6) 2.3 [0.9–5.5] 0.076 1.6 [1.1–3.8] 0.322
Marital status
Living with a partner 66 (60.0) 44 (40.0 ) 1
Living alone 63 (68.5) 29 (31.5) 1.5 [0.8–2.6] 0.212
Education
Formal 47 (54.0) 40 (46.0) 1
Non formal 82 (71.3) 33 (28.7) 2.1 [1.2–3.8] 0.012
Residence
Urban 24 (57.1) 18 (42.9) 1
Rural 105 (65.6) 55 (34.4) 1.4 [0.7–2.9] 0.310
Insurance
Insured 4 (33.3) 8 (66.7) 1
Un-insured 125 (65.8) 65 (34.2) 3.9 [1.1–13.3] 0.033
Menopausal
No 59 (61.5) 37 (38.5) 1
Yes 70 (66.0) 36 (34.0) 1.2 [0.7–2.2] 0.499
Alternative-health practitioner
No 52 (53.1) 46 (46.9) 1 1
Yes 77 (74.0) 27 (26.0) 2.5 [1.4–4.5] 0.002 2.3 [1.2–4.2] 0.011
Health facility
Highera 29 (64.4) 16 (35.6) 1
Lowerb 100 (63.7) 57 (36.3) 1.0 [0.5–1.9] 0.926
Health facility
Government 104 (63.0) 61 (37.0) 1
Private 25 (67.6) 12 (32.4) 1.2 [0.6–2.6] 0.604
Personal initiatives
Yes 45 (51.7) 42 (48.3) 1 1
No 84 (73.0) 31 (27.0) 2.5 [1.4–4.6] 0.002 2.0 [1.1–3.8] 0.028
Number of pre-referral visit
≤2 39 (54.2) 33 (45.8) 1
≥3 90 (69.2) 40 (30.8) 1.9 [1.1–3.5] 0.034
HIV status
Negative 95 (63.3) 55 (36.7) 1
Positive 28 (63.6) 16 (36.4) 1.0 [0.5–2.0] 0.971
aHospital
bHealth center and dispensary
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cultural differences, health seeking behavior and health sys-
tems. In our setting most women have no health insurance
and have never been screened for cervical cancer in their
lifetime, as compared to developed countries where most
women have insurance and are screened regularly [20]. All
factors subjected in the univariate analysis and later multi-
variate analysis may have a causal link to each other, al-
though no linkage is seen in multivariate analysis. The pre-
referral visit, lack of personal initiative to seek care, and
opting for alternative health practitioners could be attrib-
uted either to an inability of women in the community to
make their own decision regarding their health, where ei-
ther their husbands or close relatives decide for them, or
may be associated with a low level of education.
This study has several limitations. Investigations such as
intravenous pyelogram (IVP), magnetic Resonance imaging
(MRI), cystoscopy and urine for culture and sensitivity
were not performed due to limited funds. However, ultra-
sound has shown a high sensitivity for detecting hydrone-
phrosis when compared to IVP [22]. The frequency of
stage IIB, bladder metastasis and urinary tract infections
may have been underestimated as MRI, cystoscopy and
urine for culture and sensitivity were not performed. Since
this was a hospital-based study, there is possibility of
underestimating the understanding and belief within rural
communities with respect to cervical cancer.
Conclusion
Communities should be sensitized on women empower-
ment to be actively engaged in health care decision-
making, provide health education on early symptoms of
cervical cancer and the importance of early hospital
attendance when symptoms arise.
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